Main Content start here
Main Layout
Report Description

Report Description

Egypt Fertility Testing Devices Market is expected to grow at an impressive rate during the forecast period 2024-2028. The major factors include increasing awareness and acceptance of fertility testing, technological advancement in fertility testing devices, and growing demand for non-invasive and convenient fertility testing. Additionally, fertility testing devices provide a significant advantage in identifying fertility issues early on among the partners.

Fertility testing devices are medical devices used to determine a woman's fertility potential. These devices are designed to measure various parameters such as hormones, temperature, and cervical mucus that can indicate a woman's ovulation status and overall reproductive health.

In Egypt, increasing awareness and acceptance of fertility testing among couples, is contributing highly to the growth of market. According to Worldometer elaboration of latest United Nations data, the current population of Egypt is 107,687,132. Also, Egypt is the most populous country in the Arab Region and ranks 14th globally. In 2021, its population has exceeded 102 million inhabitants and will grow at an annual rate of 2%. With this growth rate, the population is projected to reach 180 million by 2052, putting Egypt amongst the top nine largestpopulations in the world by then.

There are several types of fertility testing devices available on the market. Some of the most common fertility testing devices include blood tests, fertility monitors, ovulation predictor kits, and cervical mucus monitoring. For instance, ovulation predictor kits (OPKs) are small, handheld devices that measure the level of luteinizing hormone (LH) in a woman's urine. LH is a hormone that surges just before ovulation, indicating that an egg is about to be released. OPKs are easy to use and can help women identify their most fertile days.

Cervical mucus monitoring is one such practice where the quality and quantity of cervical mucus can indicate a woman's fertility status. During ovulation, the mucus becomes thin and stretchy, resembling raw egg whites. By monitoring changes in cervical mucus, women can determine when they are most fertile. Fertility monitors are electronic devices that track multiple fertility parameters, such as LH, estrogen, and progesterone levels, as well as basal body temperature and cervical mucus. These devices can provide a more comprehensive view of a woman's fertility potential and can help identify any underlying fertility issues.

Also, blood tests can measure hormone levels such as follicle-stimulating hormone (FSH), which can indicate a woman's ovarian reserve or the number of eggs remaining in her ovaries. Blood tests can also measure other hormones such as estradiol, progesterone, and testosterone, which can help diagnose hormonal imbalances that may affect fertility. Therefore, the availability of all these various testing devices is influencing the Egypt fertility testing devices market.

Egypt Fertility Testing Devices Market

Download Free Sample Report


Growing Awareness and Acceptance of Fertility Testing

There is an increasing awareness and acceptance of fertility testing among women and couples, driven by factors such as delayed childbearing, increasing prevalence of infertility, and the desire for proactive family planning. Fertility testing can help couples identify fertility issues early on, which can lead to earlier treatment and better outcomes. Early detection can also help couples make informed decisions about family planning and reproductive health. Fertility testing can help couples identify fertility issues early on, which can lead to earlier treatment and better outcomes. Early detection can also help couples make informed decisions about family planning and reproductive health.

Infertility can be a source of stress and anxiety for couples trying to conceive. Fertility testing can provide reassurance that everything is normal, or identify the cause of infertility, which can help alleviate stress and anxiety. Fertility testing can help couples make informed decisions about family planning, such as when to start trying to conceive and whether to pursue fertility treatment. This can help couples achieve their desired family size and spacing, which can have long-term benefits on the health and wellbeing of the family.

Also, fertility testing can have economic benefits, both for individuals and society. By identifying fertility issues early on, couples can avoid the costs associated with infertility treatment, such as in vitro fertilization (IVF). Moreover, reducing infertility rates can help reduce healthcare costs and increase acceptance for in-vitro fertilization among couples suffering from infertility or serious health concerns that could lead to infertility.

Increasing Demand for Non-Invasive and Convenient Fertility Testing

Women are seeking non-invasive and convenient fertility testing methods that can be done at home, such as ovulation predictor kits, fertility monitors, and at-home hormone testing kits and is therefore contributing to the growth of the fertility testing device market. This is due to the rising awareness of fertility issues, the increasing prevalence of reproductive disorders, and the desire of individuals and couples to take control of their reproductive health.

Traditionally, fertility testing has involved invasive procedures such as blood tests, ultrasounds, and biopsies. While these methods can provide accurate information about fertility status, they are often uncomfortable and inconvenient, and may require multiple visits to a healthcare provider. However, some individuals may feel hesitant or embarrassed to undergo these procedures.

Non-invasive fertility testing methods have become more widely available in recent years. One such method is saliva testing, which involves collecting a small sample of saliva and analyzing it for hormone levels that can indicate fertility status. This method is painless, convenient, and can be done in the privacy of one's own home. Other non-invasive methods include urine testing and home fertility monitoring devices that track changes in basal body temperature and other physiological markers. Also, convenient fertility testing is particularly important for individuals and couples who are trying to conceive, as it allows them to track their fertility status over time and identify potential issues early on. It can also be useful for individuals who are not actively trying to conceive but are interested in understanding their reproductive health and planning.

Government Initiatives and Support

Fertility testing devices and services are an important aspect of reproductive healthcare in Egypt, and the government has implemented several initiatives and support programs to increase access to these services and improve their quality. One of the major initiatives in Egypt is the National Population Strategy, which was launched in 2015 and aims to promote family planning and reproductive health. According to Egypt National Population Strategy (ENPS 2015-30), the reversal of the steady state of fertility drop and the persistence of geographic disparities in population and development indicators are the two key population concerns facing the nation. Also,in March 2019,with the support of an EU-grant of 27 Million Euros, the project aims at boosting the use of voluntary, rights-based family planning through improved supply of family planning services and commodities. The strategy includes a focus on increasing access to fertility testing and counseling services for both men and women, particularly in underserved areas. Additionally, the government has also implemented a number of awareness-raising campaigns to educate the public about the importance of fertility testing and family planning. Also, the Ministry of Health and Population in Egypt has taken steps to improve the quality and availability of fertility testing services. This includes training healthcare providers in the latest techniques and technologies for fertility testing, as well as ensuring that clinics and hospitals have access to the necessary equipment and supplies.

The government has also established a number of public-private partnerships to increase access to fertility testing services. For instance, the National Population Council has partnered with private companies to provide free or low-cost fertility testing services to women in rural areas, where access to healthcare is often limited. Furthermore, the government has taken steps to regulate the fertility testing industry and ensure that providers adhere to established standards and guidelines. The Ministry of Health and Population regularly monitors fertility testing clinics and services to ensure that they meet quality standards and provide accurate information to patients.

Governments in Egypt are taking initiatives to support fertility testing and treatment, such as providing funding for infertility research, improving access to fertility services, and promoting awareness about infertility and its impact on families. It is thereby contributing to the growth of the fertility testing devices market.

Market Segmentation

The Egypt Fertility Testing Devices market can be segmented by product type, application, mode of purchase, end user, and region. Based on product type, the market is segmented into ovulation-prediction kits, fertility monitors and male fertility testing products. The fertility monitors are further segmented among urine-based ovulation tests and saliva-based ovulation tests. Based on application, the market is segmented into female fertility testing and male fertility testing. Based on the mode of purchase, the market is segmented into OTC and prescription based. Depending on the end user, the market is fragmented into hospitals, fertility clinics, and home care settings.

Market Players

Roche Diagnostics, Clearblue, Fairhaven Health, AdvaCare Pharma, Zimmer Biomet, Conmed Corporation, Boston Scientific, GE Healthcare, etc, are some of the leading companies operating in the market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2022

Estimated Year

2022

Forecast Period

2023 – 2028

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

Product Type

Application

Mode of Purchase

End user

Regional scope

 Alexandria, Suze Canal, Asyut region, Delta, Greater Cairo & Upper North Region, South upper region

Key companies profiled

Roche Diagnostics, Clearblue, Fairhaven Health, AdvaCare Pharma, Zimmer Biomet, Conmed Corporation, Boston Scientific, GE Healthcare, etc

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, Egypt Fertility Testing Devices Market, 2028, has been segmented into following categories, in addition to the industry trends which have also been detailed below:

          ·         Egypt Fertility Testing Devices Market, By Product Type

·         Ovulation Prediction Kits

·         Fertility Monitors (Urine-based Ovulation Test, Saliva-based Ovulation Test)

·         Male Fertility Testing Products

          ·         Egypt Fertility Testing Devices Market, By Application

·         Female Fertility Testing

·         Male Fertility Testing  

         ·         Egypt Fertility Testing Devices Market, Mode of Purchase

·         OTC

·         Prescription-based

         ·         Egypt Fertility Testing Devices Market, End User

·         Hospitals

·         Fertility Clinics

·         Home Care Settings

         ·         Egypt Fertility Testing Devices Market, By Region:

·         Alexandria

·         Suze Canal

·         Asyut region

·         Delta

·         Greater Cairo & Upper North Region

·         South upper region

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Egypt Fertility Testing Devices Market, 2028.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).


Egypt Fertility Testing Devices Market is an upcoming report to be released soon. If you wish early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Egypt Fertility Testing Devices Market, 2028, Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Product Type (Ovulation Prediction Kits, Fertility Monitors (Urine-based Ovulation Test, Saliva-based Ovulation Test)

5.2.2.    By Application (Female Fertility Testing v/s Male Fertility Testing)

5.2.3.    By Mode of Purchase (OTC, Prescription-based)

5.2.4.    By End User (Hospitals, Fertility Clinics, Home Care Settings)

5.2.5.    By Company (2022)

5.2.6.    By Region

5.3.  Product Market Map

6.    Egypt Prescription-based Fertility Testing Devices Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Mark et Share & Forecast

6.2.1.    By Product Type

6.2.2.    By Application

6.2.3.    By End User

7.    Egypt (Over The Counter) OTC Fertility Testing Devices Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Mark et Share & Forecast

7.2.1.    By Product Type

7.2.2.    By Application

7.2.3.    By End User

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

9.1.  Recent Developments

9.2.  Mergers & Acquisitions

9.3.  Product Developments

10. Policy & Regulatory Landscape

11. Egypt economic profile

12. Competitive Landscape

12.1.             Business Overview

12.2.             Company Snapshot

12.3.             Products & Services

12.4.             Financials (In case of listed companies)

12.5.             Recent Developments

12.6.             SWOT Analysis

12.6.1. Roche Diagnostics

12.6.2. Clearblue

12.6.3. Fairhaven Health

12.6.4. AdvaCare Pharma

12.6.5. Zimmer Biomet

12.6.6. Conmed Corporation

12.6.7. Boston Scientific

12.6.8. GE Healthcare

 13. Strategic Recommendations

Figures and Tables

Frequently asked questions

Frequently asked questions

Egypt Fertility Testing Devices Market is expected to grow at an impressive rate by 2028 on account of growing number of convenient fertility testing methods along with technological advancement in fertility testing devices. Furthermore, the increasing prevalence of infertility and growing awareness about fertility testing is propelling the market growth.

Based on the end user, Egypt Fertility Testing Devices Market is expected to be dominated by the homecare segment. This is due to factors such as easy availability of various types of fertility testing devices, frequent usability of fertility kits, and availability of non-invasive fertility testing devices in the market.

Roche Diagnostics, Clearblue, Fairhaven Health, AdvaCare Pharma, Zimmer Biomet, Conmed Corporation, Boston Scientific, GE Healthcare, etc., are some of the leading players operating in Egypt Fertility Testing Devices Market, 2028.

Cost of procedures such as manual lab-based testing and computer assisted semen analysis system is very high, which is a factor expected to obstruct the Egypt fertility testing devices market growth.

Related Reports